Cefpodoxime(200 Mg)+ Clavulanic Acid(125 Mg) in pregnancy: classified as Category C. Cefpodoxime(200 Mg)+ Clavulanic Acid(125 Mg) pregnancy safety: Category C — Use with caution. Pregnancy Teratogenic Effects Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor

Pregnancy SafetyUse With CautionFDA Cat. CAI-Verified

Is Cefpodoxime(200 Mg)+ Clavulanic Acid(125 Mg) safe during pregnancy?

Pregnancy Teratogenic Effects Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor embryocidal when administered to rats during organogenesis at doses up to 100 mg/kg/day (2 times the human dose based on mg/m2) or to rabbits at doses up to 30 mg/kg/day (1 to 2 times the human dose based on mg/m2). There are, however, no adequate and well-controlled studies of cefpodoxime proxetil use in pregnant women.

SAFECAUTIONAVOID

Overall verdict

Use With Caution

Trimester-by-Trimester Guide

40 weeks · 3 stages · different risks

CAUTION
CAUTION
CAUTION
Week 1
Week 13
Week 27Week 40
Caution

1st Trimester

Weeks 1–12 · Organs forming

Pregnancy Teratogenic Effects Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor embryocidal when administered to rats during organogenesis at doses up to 100 mg/kg/day (2 times the human dose based on mg/m2) or to rabbits at doses up to 30 mg/kg/day (1 to 2 times the human dose based on mg/m2). There are, however, no adequate and well-controlled studies of cefpodoxime proxetil use in pregnant women.

Caution

2nd Trimester

Weeks 13–26 · Baby growing

Pregnancy Teratogenic Effects Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor embryocidal when administered to rats during organogenesis at doses up to 100 mg/kg/day (2 times the human dose based on mg/m2) or to rabbits at doses up to 30 mg/kg/day (1 to 2 times the human dose based on mg/m2). There are, however, no adequate and well-controlled studies of cefpodoxime proxetil use in pregnant women.

Caution

3rd Trimester

Weeks 27–40 · Final development

Pregnancy Teratogenic Effects Pregnancy Category B Cefpodoxime proxetil was neither teratogenic nor embryocidal when administered to rats during organogenesis at doses up to 100 mg/kg/day (2 times the human dose based on mg/m2) or to rabbits at doses up to 30 mg/kg/day (1 to 2 times the human dose based on mg/m2). There are, however, no adequate and well-controlled studies of cefpodoxime proxetil use in pregnant women.

C

Category C — Use Cautiously

Animal studies show adverse effects; weigh benefits vs. risks.

Brands Available in India

Cefpodoxime(200 Mg)+ Clavulanic Acid(125 Mg) is sold under these common brand names. All contain the same active ingredient, so safety during pregnancy is identical. Tap any brand for detailed info.

AI-Verified · Based on FDA classifications + peer-reviewed sources

Not medical advice

Every pregnancy is different. Always consult your obstetrician before taking any medicine. Drug safety classifications can change — verify current guidelines with your doctor. For emergencies, call 112.

Frequently Asked Questions

Mom-to-be AI · 22 languages

Pregnancy specific sawaal? AI se directly pooch lo.

Cefpodoxime(200 Mg)+ Clavulanic Acid(125 Mg) dose, safer alternatives, trimester-specific guidance — apni language mein.

Ask Health AI

This is 50% of what GoDavaii AI shows.

Personalized Cefpodoxime(200 Mg)+ Clavulanic Acid(125 Mg) pregnancy-safety review — trimester-specific dose, FDA category explained, safer alternatives — checked against YOUR pregnancy profile.

More Pregnancy Safety Guides